<!DOCTYPE html>
<!-- paulirish.com/2008/conditional-stylesheets-vs-css-hacks-answer-neither/
-->
<!--[if lt IE 7]>
<html class="no-js lt-ie9 lt-ie8 lt-ie7" lang="en">
<![endif]-->
<!--[if IE 7]>
<html class="no-js lt-ie9 lt-ie8" lang="en">
<![endif]-->
<!--[if IE 8]>
<html class="no-js lt-ie9" lang="en">
<![endif]-->
<!--[if gt IE 8]>
<!-->
<html class="no-js" lang="en">
<!--<![endif]-->

<head>
    <meta charset="utf-8" />
    <!-- Set the viewport width to device width for mobile -->
    <meta name="viewport" content="width=device-width" />
    <title>
        PracticeUpdate : Expert Opinion Item
    </title>
    <link rel="stylesheet" href="assets/css/app.css">
    <link rel="stylesheet" href="assets/css/font-awesome.css">
    <link rel="stylesheet" href="assets/css/fc-webicons.css">
    <link rel="stylesheet" href="assets/css/foundation-icons-general.css">
    <script src="assets/js/foundation/modernizr.foundation.js">
    </script>
    <!-- IE Fix for HTML5 Tags -->
    <!--[if lt IE 9]>
        <script src="http://html5shiv.googlecode.com/svn/trunk/html5.js">
        </script>
    <![endif]-->
</head>

<body id="page" class="update off-canvas slide-nav expert-opinion-item logged-out">
    <div class="widget ad">
        <div id="leaderboard" class="Breast ad-container">
            <div class="ad-title">
                <span class="ad-title-text">
                    advertisement
                </span>
            </div>
            <!--/.ad-title-->
            <div id="leaderboardcontent" class="ad-content">
            </div>
            <!--.ad-content-->
        </div>
        <!--/#leaderboard.ad-container-->
    </div>
    <!--/.widget.ad-->
    <div class="page-header">
    </div>
    <!--/.page-header-->
    <div class="page-content">
        <section role="main">
            <div class="single-item-container">
                <article class="type-expert-opinion single-item">
                    <!-- info taken from: http://oncologystat.com/viewpoints/seminal_articles/Seminal_Articles_Germ_Cell_Tumors.html
                    -->
                    <div class="item-header-container">
                        <header class="item-header">
                            <div class="flag-container">
                                <span class="flag featured">
                                    <i class="icon-bolt">
                                    </i>
                                    featured
                                </span>
                                <span class="flag story-of-the-week">
                                    <i class="icon-bolt">
                                    </i>
                                    story of the week
                                </span>
                            </div>
                            <div class="meta pub-meta">
                                <span class="item-type">
                                    Seminal Article
                                </span>
                                <span class="item-pub-date">
                                    <time datetime="12-12-19">
                                        December 19, 2012
                                </span>
                            </div>
                            <hgroup class="item-title-container">
                                <h1 class="item-title">
                                    Seminal Articlesâ€”Gastric Cancer
                                </h1>
                                <p class="item-citation">
                                    <!-- {{source.citation}} -->
                                    2012 Jun 6, David H. Ilson, MD, PhD, Editor: Saad Sirop, MD
                                </p>
                            </hgroup>
                            <!-- /.item-title-container -->
                        </header>
                    </div>
                    <!--/.item-header-container-->
                    <div class="item-content-container">
                        <div class="item-content">
                            <div class="item-content-section">
                                <section class="seminal-article-body">
                                    <div class="seminal-article-body-container">
                                        <div class="source-container">
                                            <div class="vcard">
                                            </div>
                                            <!--/.vcard-->
                                        </div>
                                        <!--/.source-container-->
                                        <p>Based on our expert's review, here are the must-read articles for every oncologist
									  about patients with gastric cancer.</p>

									  <p><strong>Epidemiology</strong></p>

									  <p>1. Kamineni A, Williams MA, Schwartz SM, et al. The incidence of gastric carcinoma
									  in Asian migrants to the United States and their descendants. <a target="_blank" href=
									  "http://www.springerlink.com/content/u777kx7x56602371">Cancer Causes Control.
									  1999;10(1):77-83</a>.</p>

									  <p>2. Al-Refaie WB, Tseng JF, Gay G, et al. The impact of ethnicity on the presentation
									  and prognosis of patients with gastric adenocarcinoma. Results from the National Cancer
									  Data Base. <a target="_blank" href=
									  "http://onlinelibrary.wiley.com/doi/10.1002/cncr.23572/full">Cancer.
									  2008;113(3):461-469</a>. <strong>Free</strong></p>

									  <p><strong>Risk Factors</strong></p>

									  <p>3. Kubo A, Corley DA: Body mass index and adenocarcinomas of the esophagus or
									  gastric cardia: a systematic review and meta-analysis. <a target="_blank" href=
									  "http://cebp.aacrjournals.org/content/15/5/872.long">Cancer Epidemiol Biomarkers Prev.
									  2006;15(5):872-878</a>. <strong>Free</strong></p>

									  <p>4. Liu C, Russell RM: Nutrition and gastric cancer risk: an update. <a target=
									  "_blank" href=
									  "http://onlinelibrary.wiley.com/doi/10.1111/j.1753-4887.2008.00029.x/full">Nutr Rev.
									  2008;66(5):237-249</a>.</p>

									  <p>5. Huang JQ, Sridhar S, Chen Y, et al. Meta-analysis of the relationship between
									  Helicobacter pylori seropositivity and gastric cancer. <a target="_blank" href=
									  "http://www.sciencedirect.com/science/article/pii/S0016508598704226">Gastroenterology.
									  1998;114(6):1169-1179</a>.</p>

									  <p>6. Fuccio L, Zagari RM, Eusebi LH, et al. Meta-analysis: can helicobacter pylori
									  eradication treatment reduce the risk for gastric cancer? <a target="_blank" href=
									  "http://annals.org/content/151/2/121.abstract?sid=0bd93d39-8762-4b1e-874d-70b5a2801c64">
									  Ann Intern Med. 2009;151(2):121-128</a>. <strong>Free</strong></p>

									  <p>7. Uemura N, Okamoto S, Yamamoto S. Helicobacter pylori infection and the
									  development of gastric cancer. <a target="_blank" href=
									  "http://www.nejm.org/doi/full/10.1056/NEJMoa001999">N Engl J Med.
									  2001;345(11):784-789</a>. <strong>Free</strong></p>

									  <p>8. Tr&Atilde;&copy;daniel J, Boffetta P, Buiatti E, et al. Tobacco smoking and
									  gastric cancer: review and meta-analysis. <a target="_blank" href=
									  "http://onlinelibrary.wiley.com/doi/10.1002/%28SICI%291097-0215%2819970807%2972:4%3C565::AID-IJC3%3E3.0.CO;2-O/pdf">
									  Int J Cancer. 1997;72(4):565-573</a>.</p>

									  <p>9. Huntsman DG, Carneiro F, Lewis FR. Early gastric cancer in young, asymptomatic
									  carriers of germ-line E-cadherin mutations. <a target="_blank" href=
									  "http://www.nejm.org/doi/full/10.1056/NEJM200106213442504#t=article">N Engl J Med.
									  2001;344(25):1904-1909</a>. <strong>Free</strong></p>

									  <p><strong>Diagnosis and Staging</strong></p>

									  <p>10. Botet JF, Lightdate CJ, Zauber AG, et al. Preoperative staging of esophageal
									  cancer: comparison of endoscopic US and dynamic CT. <a target="_blank" href=
									  "http://radiology.rsna.org/content/181/2/419.abstract">Radiology.
									  1991;181:426-432</a>.</p>

									  <p>11. Park SR, Lee JS, Kims CG, et al. Endoscopic ultrasound and computed tomography
									  in restaging and predicting prognosis after neoadjuvant chemotherapy in patients with
									  locally advanced gastric cancer. <a target="_blank" href=
									  "http://onlinelibrary.wiley.com/doi/10.1002/cncr.23483/full">Cancer.
									  2008;112(11):2368-2376</a>. <strong>Free</strong></p>

									  <p>12. Herrmann K, Ott K, Buck AK, et al. Imaging gastric cancer with PET and the
									  radiotracers 18F-FLT and 18F-FDG: a comparative analysis. <a target="_blank" href=
									  "http://jnm.snmjournals.org/content/48/12/1945.long">J Nucl Med. 2007;
									  48(12):1945-1950</a>. <strong>Free</strong></p>

									  <p>13. Bentrem D, Gerdes H, Tang L, Brennan M, Coit D. Clinical correlation of
									  endoscopic ultrasonograohy with pathological stage and outcome in patients undergoing
									  curative resection for gastric cancer. <a target="_blank" href=
									  "http://www.springerlink.com/content/327jx882308824hx/">Ann Surg Oncol.
									  2007;14(6):1853-1859</a>.</p>

									  <p>14. Keswani RN, Early DS, Edmundowicz SA, et al. Routine PET does not alter nodal
									  staging in patients undergoing EUS-guided FNA for esophageal cancer. <a target="_blank"
									  href="http://www.sciencedirect.com/science/article/pii/S0016510708024243">Gastrointest
									  Endosc. 2009;69(7):1210-1217</a>.</p>

									  <p><strong>Surgery and Endoscopic Resection</strong></p>

									  <p>15. Bonenkamp JJ, Hermans J, Sasako M, et al. Extended lymph-node dissection for
									  gastric cancer. <a target="_blank" href=
									  "http://www.nejm.org/doi/full/10.1056/NEJM199903253401202#t=article">N Engl J Med.
									  1999; 340(12):908-914</a>. <strong>Free</strong></p>

									  <p>16. Cuschieri A, Weeden S, Fielding J, et al. Patient survival after D1 and D2
									  resections for gastric cancer: long-term results of the MRC randomized surgical trial.
									  Surgical Co-operative Group. <a target="_blank" href=
									  "http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362742/pdf/79-6690243a.pdf">Br J Cancer.
									  1999;79(9-10):1522-1530</a>. <strong>Free</strong></p>

									  <p>17. Songun I, Putter H, Kranenbarg EM, et al. Surgical treatment of gastric cancer:
									  15-year follow-up results of the randomised nationwide Dutch D1D2 trial. <a target=
									  "_blank" href=
									  "http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(10)70070-X/abstract">Lancet
									  Oncol. 2010;11(5):439-449</a>.</p>

									  <p>18. Soetikno R, Kaltenbac T, Yeh R, et al. Endoscopic mucosal resection for early
									  cancers of the upper GI tract. <a target="_blank" href=
									  "http://jco.ascopubs.org/content/23/20/4490.full">J Clin Oncol.
									  2005;23(20):4490-4498</a>.</p>

									  <p>19. Ono H, Kondo H, Gotoda T, et al. Endoscopic mucosal resection for treatment of
									  early gastric cancer. <a target="_blank" href=
									  "http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1728193/pdf/v048p00225.pdf">Gut.
									  2001;48(2):225-229</a>. <strong>Free</strong></p>

									  <p>20. Hartgrink HH, van de Velde CJ, et al. Extended lymph node dissection for gastric
									  cancer: who may benefit? Final results of the randomized Dutch gastric cancer group
									  trial. <a target="_blank" href="http://jco.ascopubs.org/content/22/11/2069.long">J Clin
									  Oncol. 2004; 22(11):2069-2077</a>.</p>

									  <p>21. Yu W, Choi GS, Chung HY. Randomized clinical trial of splenectomy versus splenic
									  preservation in patients with proximal gastric cancer. <a target="_blank" href=
									  "http://onlinelibrary.wiley.com/doi/10.1002/bjs.5353/full">Br J Surg.
									  2006;93(5):559-563</a>.</p>

									  <p>22. Sasako M, Sano T, Yamamoto S .D2 Lymphadenectomy Alone or with Para-aortic Nodal
									  Dissection for Gastric Cancer. <a target="_blank" href=
									  "http://www.nejm.org/doi/full/10.1056/NEJMoa0707035">N Engl J Med.
									  2008;359(5):453-462</a>. <strong>Free</strong></p>

									  <p><strong>Palliative Surgery for Gastric Cancer</strong></p>

									  <p>23. Jurnink SM, van Eijck CH, Steyerberg EW, et al. Stent versus gastrojujenostomy
									  tube for palliation of gastric outlet obstruction: a systematic review. <a target=
									  "_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1904222/">BMC Gastroenterol.
									  2007;7:18-27</a>. <strong>Free</strong></p>

									  <p>24. Vakil N, Morris AI, Macon N, et al. A prospective, controlled trial of covered
									  epandable metal stents in the palliation of malignant esophageal obstruction of the
									  gastroesophageal junction. <a target="_blank" href=
									  "http://www.nature.com/ajg/journal/v96/n6/full/ajg2001438a.html">Am J Gastroenterol.
									  2001;96(6):1791-1796</a>.</p>

									  <p><strong>Pathology</strong></p>

									  <p>25. Hofmann M, Stoss O, Shi D, et al. Assessment of a HER2 scoring system for
									  gastric cancer: results from a validation study. <a target="_blank" href=
									  "http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2559.2008.03028.x/full">Histopathology.
									  2008;52(7):797-805</a>.</p>

									  <p>26. Smith DD, Schwarz RR, Schwarz RE, et al. Impact of total lymph node count on
									  staging and survival after gastrectomy for gastric cancer: data from a large US
									  population database. <a target="_blank" href=
									  "http://jco.ascopubs.org/content/23/28/7114.long">J Clin Oncol.
									  2005;23(28):7114-7124</a>.</p>

									  <p><strong>Neoadjuvant and Peri-Operative Therapy</strong></p>

									  <p>27. Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus
									  surgery alone for resectable gastroesophageal cancer. <a target="_blank" href=
									  "http://www.nejm.org/doi/full/10.1056/NEJMoa055531">N Eng J Med. 2006;335(1):11-20</a>.
									  <strong>Free</strong></p>

									  <p>28. Ajani A, Winter K, Okawara GS, et al. Phase II trial of preoperative
									  chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality
									  of combined modality therapy and pathologic response. <a target="_blank" href=
									  "http://jco.ascopubs.org/content/24/24/3953.long">J Clin Oncol.
									  2006;24(24):3953-3958</a>.</p>

									  <p>29. Ychou M, Boige V, Pignon JP. Perioperative chemotherapy compared with surgery
									  alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter
									  phase III trial. <a target="_blank" href=
									  "http://jco.ascopubs.org/content/29/13/1715.full">J Clin Oncol.
									  2011;29(13):1715-1721</a>.</p>

									  <p><strong>Adjuvant Therapy</strong></p>

									  <p>30. Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery
									  compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal
									  junction. <a target="_blank" href=
									  "http://www.nejm.org/doi/full/10.1056/NEJMoa010187#t=article">N Engl J Med,
									  2001;345(1):725-30</a>. <strong>Free</strong></p>

									  <p>31. Fuchs CS, Tepper JE, Niedzwiecki D, et al. Postoperative adjuvant chemoradiation
									  for gastric or gastroesophageal junction (GEJ) adenocarcinoma using epirubicin,
									  cisplatin, and infusional (CI) 5-FU (ECF) before and after CI 5-FU and radiotherapy
									  (CRT) compared with bolus 5-FU/LV before and after CRT: Intergroup trial CALGB 80101.
									  <a target="_blank" href=
									  "http://www.asco.org/ASCOv2/Meetings/Abstracts?&amp;vmview=abst_detail_view&amp;confID=102&amp;abstractID=82318">
									  J Clin Oncol 29:2011 (suppl; abstr 4003)</a>.</p>

									  <p>32. Sasako M, Sakuramoto S, Katai H, et al. Five-Year Outcomes of a Randomized Phase
									  III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or
									  III Gastric Cancer. <a target="_blank" href=
									  "http://jco.ascopubs.org/content/29/33/4387.long">J Clin Oncol.
									  2011;29(33):4387-4393</a>.</p>

									  <p>33. Cascinu S, Labianca R, Barone C, et al. Adjuvant treatment of high-risk,
									  radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin,
									  and epidoxorubicin in a randomized controlled trial. <a target="_blank" href=
									  "http://jnci.oxfordjournals.org/content/99/8/601.long">J Natl Cancer Inst.
									  2007;99(8):601-607</a>. <strong>Free</strong></p>

									  <p>34. Bang Y, Kim YW, Yang H. Adjuvant capecitabine and oxaliplatin for gastric cancer
									  after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.
									  <a target="_blank" href=
									  "http://www.sciencedirect.com/science/article/pii/S0140673611618734">Lancet.
									  2012;379(9813):315-321</a>.</p>

									  <p>35. Paoletti X, Oba K, Burzykowski T, et al. Benefit of adjuvant chemotherapy for
									  resectable gastric cancer: a meta-analysis. <a target="_blank" href=
									  "http://jama.jamanetwork.com/article.aspx?articleid=185804">JAMA.
									  2010;303(17):1729-1737</a>.</p>

									  <p>36. Lee J, Lim do H, Kim S, et al. Phase III trial comparing capecitabine plus
									  cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy
									  in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial.
									  <a target="_blank" href="http://jco.ascopubs.org/content/30/3/268.long">J Clin Oncol.
									  2012;30(3):268-273</a>.</p>

									  <p><strong>Metastatic Disease</strong></p>

									  <p><strong>Chemotherapy</strong></p>37. Wagner AD, Grothe W, Haerting J, et al. Chemotherapy in advanced gastric
									  cancer: a systematic review and meta-analysis based on aggregate data. <a target=
									  "_blank" href="http://jco.ascopubs.org/content/24/18/2903.full">J Clin Oncol.
									  2006;24(18):2903-2909</a>.<br />
									  <br />

									  <p>38. Webb A, Cunningham D, Scarffe JH, et al. Randomized trial comparing epirubicin,
									  cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in
									  advanced esophagogastric cancer. <a target="_blank" href=
									  "http://jco.ascopubs.org/content/15/1/261.long">J Clin Oncol.
									  1997;15(1):261-267</a>.</p>

									  <p>39. Van Cutsem E, Moiseyenko VM, Tjulandin S, et al. Phase III study of docetaxel
									  and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line
									  therapy for advanced gastric cancer: a report of the V325 Study Group. <a target=
									  "_blank" href="http://jco.ascopubs.org/content/24/31/4991.long">J Clin Oncol. 2006;
									  24(31):4991-4997</a>.</p>

									  <p>40. Cunningham D, Starling N, Rao S, et al. Capecitabine and oxaliplatin for
									  advanced esophagogastric cancer. <a target="_blank" href=
									  "http://www.nejm.org/doi/full/10.1056/NEJMoa073149">N Engl J Med.
									  2008;358(1):36-46</a>. <strong>Free</strong></p>

									  <p>41. Van Cutsem E, Dicato M, Geva R, et al. The diagnosis and management of gastric
									  cancer: expert discussion and recommendations from the 12th ESMO/World Congress on
									  Gastrointestinal Cancer, Barcelona, 2010. <a target="_blank" href=
									  "http://annonc.oxfordjournals.org/content/22/suppl_5/v1.long">Ann Oncol. 2011;22(Suppl
									  5):v1-9</a>. <strong>Free</strong></p>

									  <p>42. Dank M, Zaluski J, Barone C, et al. Randomized phase III study comparing
									  irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with
									  5-fluorouracil in chemotherapy naive patients with advanced adenocarcinoma of the
									  stomach or esophagogastric junction. <a target="_blank" href=
									  "http://annonc.oxfordjournals.org/content/19/8/1450.long">Ann Oncol.
									  2008;19(8):1450-1457</a>. <strong>Free</strong></p>

									  <p>43. Kang JH, Lee SI, Lim do H. Salvage Chemotherapy for Pretreated Gastric Cancer: A
									  Randomized Phase III Trial Comparing Chemotherapy Plus Best Supportive Care With Best
									  Supportive Care Alone. <a target="_blank" href=
									  "http://jco.ascopubs.org/content/30/13/1513.full">J Clin Oncol.
									  2012;30(13):1513-8</a>.</p>

									  <p>44. Gadgeel SM, Shields AF, Heilbrun LK, et al. Phase II study of paclitaxel and
									  carboplatin in patients with advanced gastric cancer. <a target="_blank" href=
									  "http://journals.lww.com/amjclinicaloncology/Fulltext/2003/02000/Phase_II_Study_of_Paclitaxel_and_Carboplatin_in.8.aspx">
									  Am J Clin Oncol. 2003; 26(1):37-41</a>. <strong>Free</strong></p>

									  <p>45. Ajani JA, Fodor MB, Tjulandin SA, et al. Phase II multi-institutional randomized
									  trial of docetaxel plus cisplatin with or without fluorouracil in patients with
									  untreated, advanced gastric or gastroesophageal adenocarcinoma. <a target="_blank"
									  href="http://jco.ascopubs.org/content/23/24/5660.long">J Clin Oncol.
									  2005;23(24):5660-5667</a>.</p>

									  <p>46. Al-Batran SE, Hartmann JT, Probst S, et al. Phase III trial in metastatic
									  gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin
									  or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie. <a target=
									  "_blank" href="http://jco.ascopubs.org/content/26/9/1435.long">J Clin Oncol.
									  2008;26(9):1435-1442</a>.</p>

									  <p><strong>Biologics</strong></p>47. Ohtsu A, Shah MA, Van Cutsem E, et al. Bevacizumab in Combination With
									  Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized,
									  Double-Blind, Placebo-Controlled Phase III Study. <a target="_blank" href=
									  "http://jco.ascopubs.org/content/29/30/3968.long">J Clin Oncol. 2011;29:3968-3976</a>.

									  <p><br />
									  48. Bang YJ, Van Cutsem E, Feyereislova A, et al. Trastuzumab in combination with
									  chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric
									  or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised
									  controlled trial. <a target="_blank" href=
									  "http://www.sciencedirect.com/science/article/pii/S014067361061121X">Lancet.
									  2010;376(9742):687-697</a>.</p>
									</div>
                                    <!--/.seminal-article-body-container -->
                                </section>
                                <!-- /.seminal-article-body -->
                            </div>
                            <!-- ./item-content-section -->
                        </div>
                        <!-- ./item-content -->
                    </div>
                    <!-- /.item-conten-container -->
                    <hr />
                    <footer class="copyright item-footer">
                        <img class="logo" src="content/img/feed/imng_logo.gif" alt="IMNG Medical Media"
                        />
                        <p>
                            Copyright &copy; 2012 Elsevier
                        </p>
                    </footer>
            </div>
            <!--/.item-container-->
            <div class="recommended">
                <div class="recent">
                </div>
                <!--/.recent-->
                <div class="ad">
                    <img src="http://placehold.it/300x250" align="ad" title="ad" />
                </div>
            </div>
            <!--/.recommended-->
        </section>
        <!--/[role="main"]-->
        <section id="sidebar" role="complementary">
            <div class="dashboard">
                <div class="panel cta register">
                    <p>
                        <!-- Meet Our Experts -->
                        Become a member to customize this page.
                        <p>
                            <a class="button" href="#action-register">Register for free</a>
                </div>
                <!--/.panel.cta.register-->
                <div class="component user-console">
                </div>
                <!--/.component.user-console-->
                <div class="component user-topic">
                </div>
                <!--/.component.user-topic-->
                <div class="component topic-spotlight">
                </div>
                <!--/.component.topic-spotlight-->
                <div class="panel">
                    <img src="http://placehold.it/200x200" />
                    <p>
                        <!-- Meet Our Experts -->
                        Meet our Advisory and Editorial Boards comprised of physician editors
                        and world-renowned experts.
                        <p>
                </div>
            </div>
            <!--/.sidebar-->
        </section>
        <!--/.[role="complimentary"]-->
    </div>
    <!--/.page-content-->
    <footer class="page-footer">
    </footer>
    <!-- /.page-footer -->
    <!-- Included JS Files (Uncompressed) -->
    <script src="assets/js/foundation/jquery.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.accordion.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.alerts.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.buttons.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.forms.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.mediaQueryToggle.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.navigation.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.orbit.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.reveal.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.tabs.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.tooltips.js">
    </script>
    <script src="assets/js/foundation/jquery.placeholder.js">
    </script>
    <script src="assets/js/foundation/app.js">
    </script>
    <script src="assets/js/foundation/jquery.offcanvas.js">
    </script>
    <script src="assets/js/mustache.js">
    </script>
    <!-- Mustache - homepage feed template -->
    <script>
                    	<!--
	Mustache - homepage feed template -->
	$.getJSON('content/json/feed.json', function(data) {
	    $.get('assets/mustache/feed-item.mustache', function(template) {
	        //alert('Load was performed.');
	        var html = Mustache.to_html(template, data);
	        $('.stream-container').html(html);
	    });

	});

	<!--
	Mustache - homepage recent template -->
	$.getJSON('content/json/recent.json', function(data) {
	    $.get('assets/mustache/recent.mustache', function(template) {
	        //alert('Load was performed.');
	        var html = Mustache.to_html(template, data);
	        $('.recent').html(html);
	    });

	});

	<!--
	Mustache - homepage user - console template -->
	$.getJSON('content/json/user-console.json', function(data) {
	    $.get('assets/mustache/user-console.mustache', function(template) {
	        //alert('Load was performed.');
	        var html = Mustache.to_html(template, data);
	        $('.user-console').html(html);
	    });
	});

	<!--
	Mustache - homepage user - topic template -->
	$.getJSON('content/json/user-topic.json', function(data) {
	    $.get('assets/mustache/user-topic.mustache', function(template) {
	        //alert('Load was performed.');
	        var html = Mustache.to_html(template, data);
	        $('.user-topic').html(html);
	    });
	});

	<!--
	Mustache - homepage topic - spotlight template -->
	$.getJSON('content/json/topic-spotlight.json', function(data) {
	    $.get('assets/mustache/topic-spotlight.mustache', function(template) {
	        //alert('Load was performed.');
	        var html = Mustache.to_html(template, data);
	        $('.topic-spotlight').html(html);
	    });
	});
</script>
</body>

</html>